Literature DB >> 1311574

Phosphorylation of a surface receptor bound urokinase-type plasminogen activator in a human metastatic carcinomatous cell line.

K Takahashi1, H C Kwaan, K Ikeo, E Koh.   

Abstract

The 32P-labeled urokinase (uPA) bound to surface receptors of Detroit 562 cells was immunoprecipitated by anti-uPA antibody. Amino acid analysis showed that tyrosines and serines were the acceptors. Inhibition of protein kinases greatly reduced the 32P incorporation, suggesting that the respective cellular src gene product and protein kinase C were involved in the phosphorylations. Proteins purified on chromatographic columns contained two forms of uPA, a high (HMW) and a low (LMW) molecular weight. Tyrosine-phosphorylation occurs in the HMW and A-chain. Such modifications might modulate the extracellular activities of uPA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311574     DOI: 10.1016/0006-291x(92)91899-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells.

Authors:  M Gonzalez-Gronow; H E Grenett; M R Weber; G Gawdi; S V Pizzo
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

Review 2.  The plasminogen-plasmin system in malignancy.

Authors:  H C Kwaan
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

3.  Localization of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, 2 and plasminogen in colon cancer.

Authors:  H Naitoh; Y Eguchi; H Ueyama; M Kodama; T Hattori
Journal:  Jpn J Cancer Res       Date:  1995-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.